Long-Term Study Of Medicine To Prevent Alzheimer’s Raises Questions

Posted · Add Comment

The Arizona Republic (2/23, Alltucker) reports in a 3,900-word article in a series focusing on Colombians with an inherited form of early onset Alzheimer’s caused by the paisa mutation that if crenezumab, the medication being used in a long-term study, is successful in preventing Alzheimer’s in this population, “the question becomes how would it attack the more common form of Alzheimer’s.” A medicine “that treats one type of case may not treat the others.” And, “because the study is testing the concept of preventive treatment — stopping amyloid beta buildup before it starts — more questions could emerge if the drug clears these protein deposits but does not slow or halt memory and thinking problems.”

Leave a Reply

Your email address will not be published. Required fields are marked *

five − 4 =

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>